Counter-Strike: SPARTA vs GenOne (BO3) - CCT Europe Series #4 Group Stage

Platform comparison

Active sub-markets

Market context

SPARTA and GenOne are scheduled to compete in a Counter-Strike best-of-three match on 12 June at 10:00 AM ET as part of the CCT Europe Series #4 Group Stage. The fixture represents a Round 2 encounter within a regional qualifier structure that feeds into broader European competitive circuits. Current market pricing reflects zero implied probability for SPARTA victory, suggesting either strong consensus around GenOne's superiority or insufficient liquidity to establish meaningful odds.

Historical precedent from CCT Europe tournaments shows that group-stage matches between lower-seeded or less-established rosters frequently produce upset outcomes, particularly when teams have undergone recent roster changes or when preparation time differs materially between competitors. GenOne's current favouritism warrants scrutiny against their recent tournament placements and head-to-head records; the 0% pricing on SPARTA suggests either the market has priced in specific intelligence about team composition or roster availability, or the market lacks sufficient depth to reflect genuine uncertainty. Traders implementing conditional order logic should flag whether this represents genuine predictive consensus or merely thin order books.

Key catalysts include official roster confirmations from both organisations, which typically emerge 48–72 hours before match time, and any schedule adjustments announced through CCT's official channels. Monitor team social media and esports news outlets such as HLTV for last-minute stand-in announcements or technical issues that could affect preparation. The settlement window closes at 20:15 UTC on 12 June, providing a hard deadline; matches delayed beyond seven days without resolution trigger the 50-50 clause, creating tail-risk exposure for positions held through that threshold.

Methodology

We track Counter-Strike: SPARTA vs GenOne (BO3) - CCT Europe Series #4 Group Stage on the five venues with material liquidity for prediction markets. Live odds come from the Polymarket Polygon order book — the only source that ships real-time data under an open licence. For Kalshi, Betfair and Manifold we list platform attributes (fee, KYC, settlement, payment) instead of fabricated odds, because their APIs use non-comparable contract definitions.

Resolution & payout

Polymarket-based markets settle through the UMA Optimistic Oracle on Polygon. A proposer submits the outcome, a two-hour challenge window opens, and unchallenged proposals finalise the resolution. Payouts settle automatically in USDC the moment the result is final — no bookmaker, no delay.

Kalshi-based markets settle in USD via the CFTC-regulated clearinghouse. Betfair Exchange settles in GBP/EUR net of commission. Manifold is play-money and does not pay out real funds.

FAQ

Where can I trade this market with the lowest fees?

On Polymarket Review UK, which mirrors the Polymarket order book at 0% fees. Kalshi charges up to 7% per trade; Betfair Exchange takes 2-5% commission on net winnings.

Is this market available outside the US?

Polymarket Review UK is available in most jurisdictions where Polymarket isn't directly accessible. Polymarket itself is geo-blocked in the US/UK/EU. Always check local regulations.

How does resolution work?

Through the UMA Optimistic Oracle on Polygon: a proposer submits the outcome, a two-hour challenge window opens, and USDC payouts settle automatically once the result is final.

Do I need to KYC for this market?

Not under $1,500 of lifetime trading volume. Above that threshold, Polymarket Review UK triggers a quick verification flow that finishes in minutes.

How reliable are the quoted odds?

The YES/NO percentages are the live mid-prices of the Polymarket order book. On deep markets they move every few seconds; on thinner ones you'll see short plateaus.